![[F] UNHCR Rwanda Country Response Plan](/uploads/r/null/0/5/c/05c709cefc9670826925dc405797b0060a4772aed5ac7dc02aad1ef1c2bd4cfd/9fdd9dc8-52b4-4bd0-a950-c3080f40bf0e-_F__Rwanda_Country_Refugee_Response_Plan_2020-2021_-_March_2020_142.jpg)
UNHCR Rwanda Country Response Plan January 2020 – December 2021
UNCHR![[F] Update with the development of Ebola vaccines and implications of emerging evidence to inform future policy recommendations](/uploads/r/null/3/5/9/3597bba84176f2241e8a930dcddb2c893eeb9fae875d9f6cfb1dafd303d9e3b7/2fca850a-2671-400d-99ce-aeecf4b4ceb5-_F__2_Ebola_SAGE2018Oct_BgDoc_20180919_142.jpg)
![[F] WHO Ending Tuberculosis in Children.pdf](/uploads/r/null/7/e/d/7eddd5b37e7d5f92c2f4303672812b599f8002feb40225789d972c0194fc9f04/024f940c-177b-42cd-811a-024b1de1018c-_F__WHO_Ending_Tuberculosis_in_Children_142.jpg)
![[F] Why France is making eight new vaccines mandatory](/uploads/r/null/1/b/5/1b5f028151073a811ab7ac2e22c443c507a8b163a30a6d332f5bddb24bba8d3d/4dd2d185-cd5a-4516-98ea-90f85e3de0c0-_F__wardwhyfranceismaking8newvaccinesmandatory_142.jpg)
Paper on Why France is making eight new vaccines mandatory
![[Fi] Acpin homepage.pdf](/uploads/r/null/d/c/7/dc781b3c3bb81c0a61ad0c457729f35e2fa5eb917b6c8f1ad7c79f7ab8c3fa76/885eef9a-a17f-474a-bf8c-9588706bfc38-_Fi__Acpin_homepage_142.jpg)
![[Fi] NHS Seven Day Services Clinical Standards 2017.pdf](/uploads/r/null/6/5/9/659a6376b0a437758a65e04eb5d8abb614de10cec400e97428d2e4bdba4d015e/faa75457-84a8-4a2b-8ef3-c2956e033640-_Fi__NHS_Seven_Day_Services_Clinical_Standards_2017_142.jpg)
![[Fii] Acpin trial offer.pdf](/uploads/r/null/2/b/5/2b530c9146e62af26d520e9afc12665049d8575e7ed7bda7708b2bafa4838f59/726531e9-2d6e-4878-bae9-a5a9e468dc60-_Fii__Acpin_trial_offer_142.jpg)
![[Fii] NHS Seven Day Services Clinical Standards 2017.pdf](/uploads/r/null/8/d/b/8dbfbf1e9c1209b0ca47c672fc633eea7180c09dd653533223382dc7ce3b0028/1cc30155-f316-47ea-82b5-e4dc549be702-_Fii__NHS_Seven_Day_Services_Clinical_Standards_2017_142.jpg)
![[Fiii] NHS Seven Day Services Clinical Standards 2017.pdf](/uploads/r/null/6/8/0/68035559b1b6fb0afb2a5a7f61ef99155d0e674a7ccaf49de9a24435689dd0cd/7c96592e-bc81-4374-bb74-86c2a304aea5-_Fiii__NHS_Seven_Day_Services_Clinical_Standards_2017_142.jpg)
![[G] 16 October 2020 press conference, presented by Patrick Valance, estimated daily incidence – REACT-1.pdf](/uploads/r/null/1/f/a/1fa73d86f2fd917fbdfc9ef36400eb4e9ad210a9fd43c9eccac6814a17a1ffb2/e8fa7f2a-c622-439a-b622-594041d6d07f-_G__16_October_2020_press_conference__presented_by_Patrick_Valance__estimated_daily_incidence_-_REACT-1_142.jpg)
![[G] Able magazine - gripable.pdf](/uploads/r/null/0/6/c/06cb6af4567df437a49c3a5dfb50c3095a371b56961b6cf555093a350dec327c/99fb5d5e-a199-4de9-9cd5-0894715b16b0-_G__Able_magazine_-_gripable_142.jpg)
![[G] Academy of Medical Sciences, Preparing for a Challenging Winter, 14th July 2020 commissioned by the Chief Scientific Advisor.pdf](/uploads/r/null/3/0/f/30f48d9c8d43dfcce18eeb4ed158bdcc7f4df4081788992aad30e906b1c5fd18/b2c81b8c-fba7-45ee-bc38-5c061828ff75-_G__Academy_of_Medical_Sciences__Preparing_for_a_Challenging_Winter__14th_July_2020_commissioned_by_the_Chief_Scientific_Advisor_142.jpg)
![[G] Accenture labs report on Quantum Computing](/uploads/r/null/f/3/9/f39211de2a0b194a9659e16e43de0321c73e8f2cf8213f22d7f7290e18732b1a/49e53576-fba5-41cb-94ef-07f6fe347ec3-_G__Accenture_Quantum_Computing_142.jpg)
![[G] Amazon sales page of BioMin toothpaste](/uploads/r/null/e/b/d/ebd69e569a57017d93b3948c6f95ebe5d43847552ef58aa13664225b935381fa/1908963a-db38-4229-8c50-bb5f8a257945-_G__screencapture-amazon-co-uk-toothpaste-EasyPick-support-remineralisation-cleaning-dp-B01N901QRD-2021-03-02-10_07_33_142.jpg)
![[G] Assessment of the impact of the extension of vaccination mandates on vaccine coverage after 1 year](/uploads/r/null/d/1/1/d1109fa6c1946754bf9b63aea0c221a5f43e5010bb11c9086eb49ee0e4ae5645/a913de59-d83e-4f8e-89f2-d7b6f7a585b3-_G__eurosurv-24-26-2_142.jpg)
Paper looking at the effect of the vaccination programme in France cites underpinning research
![[G] Better Future. A Route Map to Creating a Cleantech Cluster in London.](/uploads/r/null/8/9/8/898e40b51c22b556b0cce111cc9ebd473c9a7ff2fde0b544368ce192d9659585/6a459c2e-d266-4898-9b1d-09160128308f-_G__lsdc_-_better_future_report_2016_142.jpg)
Report from the London Sustainable Development Commission (LSDC) - A route map creating a Cleantech cluster in London
![[G] Cairn Fluorescence Lifetime Imaging Module - Description](/uploads/r/null/d/e/e/dee17745b6579d8a81a99583432570ba81325a8873708db02e5adaab1cc4246b/7c8ad426-a56a-47ca-9704-6689978ee74b-_G__screencapture-cairn-research-co-uk-product-fluorescence-lifetime-imaging-module-2021-01-18-10_31_16_142.jpg)
Web page of openScopes presenting mlow-cost, modular, open source microscopy components including the openFrame and openFLIM showing the FLIM module referencing the FLIM resources of the Photonics team at Imperial
Cairn research![[G] Case Study Ripple Mapping Dr. Atwater - YouTube.pdf](/uploads/r/null/9/8/4/9844ccf044e1d3b36ffcdfce4865363310d4de64b76d3fc39b94f87a315f35b5/4fd4b237-6192-42e7-971f-b7123f795fe7-_G__Case_Study_Ripple_Mapping_Dr._Atwater_-_YouTube_142.jpg)
![[G] CT7001, a Novel Orally Bio-Available CDK7 Inhibitor, Is Highly Active in in-Vitro and in-Vivo Models of AML](/uploads/r/null/9/8/f/98f0be0cc74976d6172fdfef26146097b9e6cf93bddfe925ff86c5ab602b551e/613e972b-13ae-4ef0-abd2-fb7eaa3af5a9-_G__ashpublications-org-blood-article-2020-08-27-15_19_51_142.jpg)
Early results from CT7001
![[G] Dr Foster Limited - Company Profile - Endole](/uploads/r/null/8/9/d/89d119b18321d59e17bc5c8df5966dfa301584069d6282ff2376b06cda9da9d2/b24bc208-b657-4277-aca5-71e888966d28-_G__Dr_Foster_Limited_-_Company_Profile_-_Endole_142.jpg)
Dr Foster Limited’s size as a company
gives figures for the year ending June 2019